Stocks
Fate Therapeutics (FATE) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -31.3% | -58.2% | -43.7% | -58.4% | -65.8% | -65.8% | ||
| Changes by years, y/y, % | +13pp | -27pp | +15pp | -15pp | -7pp | +8.2% | |||
Fate Therapeutics. ROE, %
Fate Therapeutics. ROE, changes, pp
Fate Therapeutics (FATE) ROE US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| ROE, % | ? | -58.4% | -61.0% | -65.6% | -66.7% | -65.8% | -65.8% | |
| Changes by years, y/y, % | -15pp | -16pp | -21pp | -17pp | -7pp | |||
| Changes by quarters, q/q, % | -9pp | -3pp | -5pp | -1pp | +1pp | |||
